» Articles » PMID: 29384860

Bilateral Subthalamic Deep Brain Stimulation Initial Impact on Nonmotor and Motor Symptoms in Parkinson's Disease: An Open Prospective Single Institution Study

Abstract

Numerous studies document significant improvement in motor symptoms in patients with Parkinson's disease (PD) after deep brain stimulation of the subthalamic nucleus (STN-DBS). However, little is known about the initial effects of STN-DBS on nonmotor domains.Our objective was to elucidate the initial effects of STN-DBS on non-motor and motor symptoms in PD patients in a 4-month follow-up.This open prospective study followed 24 patients with PD who underwent STN-DBS. The patients were examined using dedicated rating scales preoperatively and at 1 and 4 months following STN-DBS to determine initial changes in motor and nonmotor symptoms. Patients at month 1 after STN-DBS had significantly reduced the Parkinson's disease Questionnaire scores (P = .018) and Scales for Outcomes in Parkinson's disease - Autonomic scores (P = .002); these scores had increased at Month 4 after DBS-STN. Nonmotor Symptoms Scale for Parkinson's Disease had improved significantly at Month 1 (P < .001); at Month 4, it remained significantly lower than before stimulation (P = .036). There was no significant difference in The Parkinson's Disease Sleep Scaleat Month 1 and significant improvement at Month 4 (P = .026). There were no significant changes in The Female Sexual Function Index or International Index of Erectile Function. Movement Disorder Society Unified Parkinson's Disease Rating Scale, Part III scores show significant improvements at Month 1 (P < .001) and at Month 4 (P < .001).STN-DBS in patients with advanced PD clearly improves not only motor symptoms, but also several domains of nonmotor functions, namely sleep, autonomic functions and quality of life quickly following the start of stimulation.

Citing Articles

Impact of deep brain stimulation on urogenital function in Parkinson's disease: a systematic review and meta-analysis.

Gao L, Wang M, Zhou M, Yin W, Cao X Front Neurol. 2024; 15:1397344.

PMID: 39026583 PMC: 11254620. DOI: 10.3389/fneur.2024.1397344.


Short term cardiovascular symptoms improvement after deep brain stimulation in patients with Parkinson's disease: a systematic review.

Cucinotta F, Swinnen B, Makovac E, Hirschbichler S, Pereira E, Little S J Neurol. 2024; 271(7):3764-3776.

PMID: 38809271 PMC: 11233308. DOI: 10.1007/s00415-024-12459-1.


Alterations of non-motor symptoms in Parkinson's disease, after of subthalamic deep brain stimulation.

Mandat V, Zdunek P, Krolicki B, Mandat T World Neurosurg X. 2024; 23:100375.

PMID: 38623314 PMC: 11017340. DOI: 10.1016/j.wnsx.2024.100375.


Neuroprosthetics: from sensorimotor to cognitive disorders.

Gupta A, Vardalakis N, Wagner F Commun Biol. 2023; 6(1):14.

PMID: 36609559 PMC: 9823108. DOI: 10.1038/s42003-022-04390-w.


Downregulation of CDK5 signaling in the dorsal striatum alters striatal microcircuits implicating the association of pathologies with circadian behavior in mice.

Zhou H, Zhang J, Shi H, Li P, Sui X, Wang Y Mol Brain. 2022; 15(1):53.

PMID: 35701839 PMC: 9195255. DOI: 10.1186/s13041-022-00939-2.


References
1.
Faggiani E, Benazzouz A . Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: From history to the interaction with the monoaminergic systems. Prog Neurobiol. 2016; 151:139-156. DOI: 10.1016/j.pneurobio.2016.07.003. View

2.
Ineichen C, Baumann-Vogel H, Christen M . Deep Brain Stimulation: In Search of Reliable Instruments for Assessing Complex Personality-Related Changes. Brain Sci. 2016; 6(3). PMC: 5039469. DOI: 10.3390/brainsci6030040. View

3.
Pfeiffer R . Non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2015; 22 Suppl 1:S119-22. DOI: 10.1016/j.parkreldis.2015.09.004. View

4.
Chaudhuri K, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R . The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002; 73(6):629-35. PMC: 1757333. DOI: 10.1136/jnnp.73.6.629. View

5.
Rodriguez-Blazquez C, Forjaz M, Frades-Payo B, de Pedro-Cuesta J, Martinez-Martin P . Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT). Eur J Neurol. 2009; 17(2):194-201. DOI: 10.1111/j.1468-1331.2009.02788.x. View